Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)

Abstract Background The emergency set-up and implementation of outpatient clinical trials on epidemic emerging infectious diseases such as COVID-19 raise many issues in terms of research structuration, regulations, and health systems organization. We aimed to describe the experience and points of vi...

Full description

Bibliographic Details
Main Authors: Carine Grenier, Macha Loniewski, Mélanie Plazy, Racha Onaisi, Marie-Hélène Doucet, Jean-Philippe Joseph, Alexandre Duvignaud, Denis Malvy, Xavier Anglaret, Joanna Orne-Gliemann, the Coverage study group
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Archives of Public Health
Subjects:
Online Access:https://doi.org/10.1186/s13690-022-00999-9
_version_ 1797985537180565504
author Carine Grenier
Macha Loniewski
Mélanie Plazy
Racha Onaisi
Marie-Hélène Doucet
Jean-Philippe Joseph
Alexandre Duvignaud
Denis Malvy
Xavier Anglaret
Joanna Orne-Gliemann
the Coverage study group
author_facet Carine Grenier
Macha Loniewski
Mélanie Plazy
Racha Onaisi
Marie-Hélène Doucet
Jean-Philippe Joseph
Alexandre Duvignaud
Denis Malvy
Xavier Anglaret
Joanna Orne-Gliemann
the Coverage study group
author_sort Carine Grenier
collection DOAJ
description Abstract Background The emergency set-up and implementation of outpatient clinical trials on epidemic emerging infectious diseases such as COVID-19 raise many issues in terms of research structuration, regulations, and health systems organization. We aimed to describe the experience and points of view of different stakeholders involved in a French home-based outpatient trial on COVID-19 and to identify the early barriers and facilitators to the trial implementation. Methods We conducted a mixed-methods study in July 2020. A self-administered questionnaire was emailed to 213 clinical, operational and research stakeholders involved in the Coverage trial; individual semi-directed interviews were conducted among 14 stakeholders. Questionnaire data and written interview notes are presented together by key theme. Results One hundred fifty six stakeholders responded to the questionnaire. 53.4% did not have prior experience in clinical research. The motivation of most stakeholders to participate in the Coverage trial was to feel useful during the pandemic. 87.9% agreed that the trial had an unusual set-up timeframe, and many regretted a certain lack of regulatory flexibility. Mobile medical teams and specific professional skills were perceived as instrumental for outpatient research. Conclusions The implementation of a home-based outpatient clinical trial on COVID-19 was perceived as relevant and innovative although requiring important adaptations of usual professional responsibilities and standard research procedures. Lessons learned from the Coverage trial underline the need for improved networks between hospital and community medicine, and call for a dedicated and reactive outpatient research platform on emerging or threatening infectious diseases.
first_indexed 2024-04-11T07:19:46Z
format Article
id doaj.art-450c10513c634982800b538120e215d5
institution Directory Open Access Journal
issn 2049-3258
language English
last_indexed 2024-04-11T07:19:46Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Archives of Public Health
spelling doaj.art-450c10513c634982800b538120e215d52022-12-22T04:37:48ZengBMCArchives of Public Health2049-32582022-12-0180111010.1186/s13690-022-00999-9Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)Carine Grenier0Macha Loniewski1Mélanie Plazy2Racha Onaisi3Marie-Hélène Doucet4Jean-Philippe Joseph5Alexandre Duvignaud6Denis Malvy7Xavier Anglaret8Joanna Orne-Gliemann9the Coverage study groupUniversity of BordeauxUniversity of BordeauxUniversity of BordeauxDepartment of General Practice, University of BordeauxUniversity of BordeauxDepartment of General Practice, University of BordeauxUniversity of BordeauxUniversity of BordeauxUniversity of BordeauxUniversity of BordeauxAbstract Background The emergency set-up and implementation of outpatient clinical trials on epidemic emerging infectious diseases such as COVID-19 raise many issues in terms of research structuration, regulations, and health systems organization. We aimed to describe the experience and points of view of different stakeholders involved in a French home-based outpatient trial on COVID-19 and to identify the early barriers and facilitators to the trial implementation. Methods We conducted a mixed-methods study in July 2020. A self-administered questionnaire was emailed to 213 clinical, operational and research stakeholders involved in the Coverage trial; individual semi-directed interviews were conducted among 14 stakeholders. Questionnaire data and written interview notes are presented together by key theme. Results One hundred fifty six stakeholders responded to the questionnaire. 53.4% did not have prior experience in clinical research. The motivation of most stakeholders to participate in the Coverage trial was to feel useful during the pandemic. 87.9% agreed that the trial had an unusual set-up timeframe, and many regretted a certain lack of regulatory flexibility. Mobile medical teams and specific professional skills were perceived as instrumental for outpatient research. Conclusions The implementation of a home-based outpatient clinical trial on COVID-19 was perceived as relevant and innovative although requiring important adaptations of usual professional responsibilities and standard research procedures. Lessons learned from the Coverage trial underline the need for improved networks between hospital and community medicine, and call for a dedicated and reactive outpatient research platform on emerging or threatening infectious diseases.https://doi.org/10.1186/s13690-022-00999-9CovidTreatmentAmbulatoryPerceptionsImplementation
spellingShingle Carine Grenier
Macha Loniewski
Mélanie Plazy
Racha Onaisi
Marie-Hélène Doucet
Jean-Philippe Joseph
Alexandre Duvignaud
Denis Malvy
Xavier Anglaret
Joanna Orne-Gliemann
the Coverage study group
Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
Archives of Public Health
Covid
Treatment
Ambulatory
Perceptions
Implementation
title Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
title_full Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
title_fullStr Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
title_full_unstemmed Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
title_short Implementing an outpatient clinical trial on COVID-19 treatment in an emergency epidemic context: a mixed methods study among operational and research stakeholders within the Coverage trial, Bordeaux (France)
title_sort implementing an outpatient clinical trial on covid 19 treatment in an emergency epidemic context a mixed methods study among operational and research stakeholders within the coverage trial bordeaux france
topic Covid
Treatment
Ambulatory
Perceptions
Implementation
url https://doi.org/10.1186/s13690-022-00999-9
work_keys_str_mv AT carinegrenier implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT machaloniewski implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT melanieplazy implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT rachaonaisi implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT mariehelenedoucet implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT jeanphilippejoseph implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT alexandreduvignaud implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT denismalvy implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT xavieranglaret implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT joannaornegliemann implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance
AT thecoveragestudygroup implementinganoutpatientclinicaltrialoncovid19treatmentinanemergencyepidemiccontextamixedmethodsstudyamongoperationalandresearchstakeholderswithinthecoveragetrialbordeauxfrance